189 related articles for article (PubMed ID: 15191948)
1. In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis.
Saudemont A; Quesnel B
Blood; 2004 Oct; 104(7):2124-33. PubMed ID: 15191948
[TBL] [Abstract][Full Text] [Related]
2. NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells.
Saudemont A; Jouy N; Hetuin D; Quesnel B
Blood; 2005 Mar; 105(6):2428-35. PubMed ID: 15536145
[TBL] [Abstract][Full Text] [Related]
3. B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer.
Liu Y; Zeng B; Zhang Z; Zhang Y; Yang R
Clin Immunol; 2008 Dec; 129(3):471-81. PubMed ID: 18790673
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer of CD154 and IL12 cDNA induces an anti-leukemic immunity in a murine model of acute leukemia.
Saudemont A; Buffenoir G; Denys A; Desreumaux P; Jouy N; Hetuin D; Bauters F; Fenaux P; Quesnel B
Leukemia; 2002 Sep; 16(9):1637-44. PubMed ID: 12200675
[TBL] [Abstract][Full Text] [Related]
5. Cytosine arabinoside induces costimulatory molecule expression in acute myeloid leukemia cells.
Vereecque R; Saudemont A; Quesnel B
Leukemia; 2004 Jul; 18(7):1223-30. PubMed ID: 15152266
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific regression of established tumors induced by active immunization with irradiated IL-12- but not B7-1-transfected tumor cells.
Fallarino F; Ashikari A; Boon T; Gajewski TF
Int Immunol; 1997 Sep; 9(9):1259-69. PubMed ID: 9310829
[TBL] [Abstract][Full Text] [Related]
7. A fiber-modified adenoviral vector interacts with immunoevasion molecules of the B7 family at the surface of murine leukemia cells derived from dormant tumors.
Grellier E; Lécolle K; Rogée S; Couturier C; D'Halluin JC; Hong SS; Fender P; Boulanger P; Quesnel B; Colin M
Mol Cancer; 2011 Aug; 10():105. PubMed ID: 21884581
[TBL] [Abstract][Full Text] [Related]
8. In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors.
Berthon C; Driss V; Liu J; Kuranda K; Leleu X; Jouy N; Hetuin D; Quesnel B
Cancer Immunol Immunother; 2010 Dec; 59(12):1839-49. PubMed ID: 20814675
[TBL] [Abstract][Full Text] [Related]
9. Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model.
Okudaira K; Hokari R; Tsuzuki Y; Okada Y; Komoto S; Watanabe C; Kurihara C; Kawaguchi A; Nagao S; Azuma M; Yagita H; Miura S
Int J Oncol; 2009 Oct; 35(4):741-9. PubMed ID: 19724910
[TBL] [Abstract][Full Text] [Related]
10. Limited importance of CD40/CD40L interaction in the B7-dependent generation of anti-MOPC-315 cytotoxic T lymphocyte activity by tumor bearer splenic cells stimulated in vitro in the presence of tumor necrosis factor.
Kalinichenko TV; Mokyr MB
Cancer Immunol Immunother; 1998 Aug; 46(6):293-303. PubMed ID: 9756413
[TBL] [Abstract][Full Text] [Related]
11. B7-CTLA4 interaction enhances both production of antitumor cytotoxic T lymphocytes and resistance to tumor challenge.
Zheng P; Wu Y; Guo Y; Lee C; Liu Y
Proc Natl Acad Sci U S A; 1998 May; 95(11):6284-9. PubMed ID: 9600957
[TBL] [Abstract][Full Text] [Related]
12. B7-2 expression on tumor cells is important for the acquisition of cytotoxic T lymphocyte activity by spleen cells from low-dose-melphalan-treated MOPC-315 tumor bearers via a mechanism that requires either B7-1 or B7-2 expression on host antigen-presenting cells.
Sojka DK; La Motte RN; Mokyr MB
Cancer Immunol Immunother; 2000 Apr; 49(1):10-22. PubMed ID: 10782862
[TBL] [Abstract][Full Text] [Related]
13. Expression of programmed death 1 ligands by murine T cells and APC.
Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antiviral T cell function in the absence of B7-H1 is insufficient to prevent persistence but exacerbates axonal bystander damage during viral encephalomyelitis.
Phares TW; Stohlman SA; Hinton DR; Atkinson R; Bergmann CC
J Immunol; 2010 Nov; 185(9):5607-18. PubMed ID: 20876353
[TBL] [Abstract][Full Text] [Related]
15. Microparticulate beta-glucan upregulates the expression of B7.1, B7.2, B7-H1, but not B7-DC on cultured murine peritoneal macrophages.
Hunter KW; DuPre' S; Redelman D
Immunol Lett; 2004 Apr; 93(1):71-8. PubMed ID: 15134902
[TBL] [Abstract][Full Text] [Related]
16. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity.
Hirano F; Kaneko K; Tamura H; Dong H; Wang S; Ichikawa M; Rietz C; Flies DB; Lau JS; Zhu G; Tamada K; Chen L
Cancer Res; 2005 Feb; 65(3):1089-96. PubMed ID: 15705911
[TBL] [Abstract][Full Text] [Related]
17. B7-H1 maintains the polyclonal T cell response by protecting dendritic cells from cytotoxic T lymphocyte destruction.
Chen L; Azuma T; Yu W; Zheng X; Luo L; Chen L
Proc Natl Acad Sci U S A; 2018 Mar; 115(12):3126-3131. PubMed ID: 29507197
[TBL] [Abstract][Full Text] [Related]
18. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.
Dong H; Strome SE; Salomao DR; Tamura H; Hirano F; Flies DB; Roche PC; Lu J; Zhu G; Tamada K; Lennon VA; Celis E; Chen L
Nat Med; 2002 Aug; 8(8):793-800. PubMed ID: 12091876
[TBL] [Abstract][Full Text] [Related]
20. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
